We thank Drs. Kempen and Pinsker for their remarks on our article. 1The main criticism of these two letters is that because outcome of partially paralyzed patients in the postoperative setting was not extensively evaluated, there is not enough evidence to recommend a quantitative evaluation of neuromuscular blockade or to promote universal reversal in presence of a partial paralysis at the end of the procedure. We agree with the first part of the comment. Indeed, our study was not designed to assess adverse events induced by partial paralysis. Our aim was limited to the determination of the incidence of partial paralysis at arrival in the PACU following the administration of a single dose of nondepolarizing muscle relaxant with an intermediate duration of action. This was done only to alert physicians that a time interval longer than 2 h after tracheal intubation to the end of the surgical procedure does not guarantee full recovery. Numerous studies have already demonstrated that moderate degree of paralysis (train-of-four ratio between 0.7 to 0.9) impedes physiologic pathways during early recovery. These alterations particularly affect respiratory response to hypoxemia, 2,3and the ability to swallow, a mechanism involved in the upper airway protection from inhalation after extubation. 4–6In our study, we tried to demonstrate that quantitative monitoring (i.e. , train-of-four ratio measurement) is a valuable tool to detect a low degree of residual paralysis with a good accuracy while qualitative instrumental tests and clinical test (head-lift) are not sensitive enough. To resume, there is enough scientific evidence to think that residual paralysis is not advantageous to the patient, even if it is not necessarily deleterious. Thereafter, anesthesiologists can detect quantitatively moderate residual paralysis levels and have long known how to accelerate recovery using different reversal agents (neostigmine or edrophonium). Therefore, and as mentioned in the editorial view accompanying our article, 7why not use all of these facts to improve our patient’s safety?
Skip Nav Destination
Correspondence| February 2004
Neuromuscular Monitoring Advancement: In Reply
Bertrand Debaene, M.D.;
Anesthesiology February 2004, Vol. 100, 454.
- Views Icon Views
- Share Icon Share
- Search Site
Bertrand Debaene, Benoit Plaud; Neuromuscular Monitoring Advancement: In Reply. Anesthesiology 2004; 100:454 doi: https://doi.org/10.1097/00000542-200402000-00045
Download citation file:
Citing articles via
Practice Guidelines for Preoperative Fasting and the Use of Pharmacologic Agents to Reduce the Risk of Pulmonary Aspiration: Application to Healthy Patients Undergoing Elective Procedures: An Updated Report by the American Society of Anesthesiologists Task Force on Preoperative Fasting and the Use of Pharmacologic Agents to Reduce the Risk of Pulmonary Aspiration